The WHO's Efforts to Control Human African Trypanosomiasis (Sleeping Sickness) from 2000 to 2009
Author Information
Author(s): Simarro Pere P., Diarra Abdoulaye, Ruiz Postigo Jose A., Franco José R., Jannin Jean G.
Primary Institution: World Health Organization
Conclusion
The number of new cases of human African trypanosomiasis reported to WHO has dropped below 10,000 for the first time in 50 years, indicating significant progress in control efforts.
Supporting Evidence
- WHO's support led to a significant reduction in the use of melarsoprol for treating second stage gambiense cases.
- Training programs were implemented to improve the capacity of health staff in endemic countries.
- WHO's initiatives resulted in a 63% decrease in reported cases since 2000.
Takeaway
The WHO and its partners have worked hard to reduce the number of people getting sick from sleeping sickness, and now fewer than 10,000 new cases are reported each year.
Methodology
The WHO provided technical assistance, access to diagnosis and treatment, and training to health staff in endemic countries.
Potential Biases
Potential bias due to reliance on reported cases, which may underestimate the true number of infections.
Limitations
The decline in support from NGOs and bilateral cooperation poses a risk to the sustainability of control efforts.
Participant Demographics
Countries listed as endemic for human African trypanosomiasis, including Benin, Burkina Faso, Cameroon, and others.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website